Want to join the conversation?
$CMS reaffirmed its 2016 adjusted EPS guidance of $1.99-2.02. This is consistent with the company's 2016 plan of 5-7% annual adjusted EPS growth. Starting in 2017, CMS has increased its adjusted EPS growth guidance to 6-8% based on projected increases in capital investment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?